This may be complemented by the definition of A2AR polymorphisms as an ancillary biomarker for the susceptibility and evolution of brain diseases, which still requires a firm establishment of structural-functional relationships between A2AR polymorphisms and brain dysfunction. This evidence concerns the gene ADORA2A and brain disorder.